Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2025-12-17 @ 6:26 AM
Study NCT ID:
NCT06384352
Status:
None
Last Update Posted:
2025-08-29 00:00:00
First Post:
2024-03-26 00:00:00
Brief Title:
A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Sponsor:
Organization:
MediLink Therapeutics (Suzhou) Co., Ltd.